Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis?

Nature Clinical Practice Rheumatology volume 2, pages 72–73 (2006)Cite this article

boxed-textBraun J et al. (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52: 2447–2451

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rosenbaum J et al. (2002) Anti-TNF therapy for eye involvement in spondyloarthropathy. Clin Exp Rheumatol 20 (Suppl 28): S67–S70

    Google Scholar 

  2. Kim HS et al. (2001) The expression of multiple cytokines and inducible nitric oxide synthase in experimental melanin-protein-induced uveitis. Ophthalmic Res 33: 329–335

    Article  CAS  Google Scholar 

  3. Lapadula G (2005) Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases. Reumatismo 57 (Suppl 1): 22–29

    CAS  PubMed  Google Scholar 

  4. Jabs et al. (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140: 509–516

    Article  Google Scholar 

  5. Suhler EB et al. (2005) A prospective trial of infliximab therapy for refractory uveitis. Arch Ophthalmol 123: 903–912

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by the Commentary author and Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Director of the Uveitis and Ocular Immunology Fellowship,

    Grace Levy-Clarke & Robert Nussenblatt

  2. Laboratory of Immunology at the National Eye Institute, NIH, Bethesda, MD, USA

    Grace Levy-Clarke & Robert Nussenblatt

Authors
  1. Grace Levy-Clarke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Nussenblatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Grace Levy-Clarke.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levy-Clarke, G., Nussenblatt, R. Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis?. Nat Rev Rheumatol 2, 72–73 (2006). https://doi.org/10.1038/ncprheum0097

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0097

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing